Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New migraine pill under the tongue shows promise in early trial

NCT ID NCT06728553

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times

Summary

This study tested whether a new under-the-tongue drug called MTX101 can safely relieve migraine headaches in adults. 78 participants took either the drug or a placebo during a migraine attack and recorded their pain levels and any side effects. The goal was to see if MTX101 reduces headache pain and the need for rescue medication.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Brainstorm Research

    Miami, Florida, 33176, United States

  • Clinical Research Institute, LLC

    Santa Monica, California, 90048, United States

  • DelRicht Research

    New Orleans, Louisiana, 70115, United States

  • Kaizen Brain Center

    La Jolla, California, 92037, United States

  • QUEST Research Institute

    Farmington Hills, Michigan, 48334, United States

  • Synergy Clinical Research/Emerald Coast Center for Neurological Disorders

    Pensacola, Florida, 32504, United States

  • Wasatch Clinical Research

    Salt Lake City, Utah, 84107, United States

Conditions

Explore the condition pages connected to this study.